Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Breast Cancer Research and Treatment|October 23, 2021
Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancerPauline Corbaux, Audrey Lardy-Cleaud, Marie Alexandre, et al.
European Journal of Cancer (Oxford, England : 1990)|September 30, 2018
UCBG 2-08: 5-year efficacy results from the UNICANCER-PACS08 randomised phase III trial of adjuvant treatment with FEC100 and then either docetaxel or ixabepilone in patients with early-stage, poor prognosis breast cancerMario Campone, Magali Lacroix-Triki, Lise Roca, et al.
Breast Cancer Research and Treatment|October 26, 2018
Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimensLuc Cabel, Matthieu Carton, Bianca Cheaib, et al.
Breast (Edinburgh, Scotland)|August 9, 2022
Efficacy of taxanes rechallenge in first-line treatment of early metastatic relapse of patients with HER2-negative breast cancer previously treated with a (neo)adjuvant taxanes regimen: A multicentre retrospective observational studyAntoine Vasseur, Matthieu Carton, Severine Guiu, et al.
European Journal of Cancer (Oxford, England : 1990)|February 17, 2022
Impact of lobular versus ductal histology on overall survival in metastatic breast cancer: a French retrospective multicentre cohort studyFlorence Dalenc, Amélie Lusque, Thibault De La Motte Rouge, et al.
International Journal of Cancer|May 16, 2019
Real-life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME programWilliam Jacot, Pierre-Etienne Heudel, Julien Fraisse, et al.
International Journal of Cancer|September 26, 2022
Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real-world databaseAudrey Mailliez, Veronique D'Hondt, Amelie Lusque, et al.
Therapeutic Advances in Medical Oncology|February 22, 2021
Real-life prognosis of 5041 bone-only metastatic breast cancer patients in the multicenter national observational ESME programMarion Bertho, Julien Fraisse, Anne Patsouris, et al.
Therapeutic Advances in Medical Oncology|March 3, 2022
Clinicopathological characteristics and prognosis of breast cancer patients with isolated central nervous system metastases in the multicentre ESME databaseMarcela Carausu, Matthieu Carton, Luc Cabel, et al.
The Lancet. Oncology|September 14, 2020
Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 studyKarim Fizazi, Gero Kramer, Jean-Christophe Eymard, et al.
Pageof 7